Bio Logbook Services
Optimizing clinical research studies: our support
Optimize your clinical studies with Bio Logbook Services, designed for pharmaceutical, hospital and academic research.
Our tailor-made support and innovative software analyze biological data using biological drift and advanced predictive models.
Reduce risks, speed up your trials and obtain more reliable results for more effective clinical research.
How does Bio Logbook improve your clinical trials?
Accelerate and deristify your studies
Optimize participant selection
Improve safety monitoring
Monitor treatment effects with precision
Access predictions of other treatment effects
Accelerate and deristify your studies
Rethinking the way biological results are interpreted thanks to the notion of drift
With Bio Logbook Services software, you can speed up and streamline your clinical trials, while gaining a clearer picture of treatment effects.
Bio Logbook software offers you an innovative methodology for monitoring the biological results of clinical trial participants. It allows you to rethink the way you interpret biological results, thanks to the notion of drift, enabling a better understanding of physio-pathological phenomena and even the prediction of additional clinical outcomes.
Optimize participant selection
Optimizing cohort selection
Thanks to the fine analysis of biology data, the tool will enable you to optimize cohort selection and make them more homogeneous, thus improving the processing of results for analysis of the efficacy of the treatment tested.
Improve safety monitoring
Early detection of biological imbalances
Bio Logbook compares participants' biological values with personalized optima, thus detecting potential imbalances at an early stage. This approach reduces patient safety risks and improves monitoring of side effects.
Monitor treatment effects with precision
Measure an early level of biological drift to monitor treatment effects, from the very first biological variations measured.
Analyze biological variations as soon as they occur. Bio Logbook measures biological deviations, even within normal values, to give you an in-depth understanding of the effects of treatment.
Access predictions of other treatment effects
Access prognoses for biological parameters not tested in the trial
The software also gives you access to predictions of biological parameters not tested during the trial, predicted by artificial intelligence. In this way, we are able to predict, with a high level of accuracy, the probability of a biological parameter being outside the threshold value, thus providing a wealth of additional information on the effects of treatment.
How does it work?
Bio Logbook Healthcare
Discover Bio Logbook Healthcare, the medical decision-support software that is revolutionizing biological analysis. Detect biological imbalances early and estimate unmeasured parameters, for more precise, personalized diagnoses.
Our collaborations
They trust us and rely on our expertise. Discover our recent collaborations.
Bio Logbook partners with Axians Digital Healthcare
Bio Logbook announces a strategic partnership with Axians Digital Healthcare, the digital healthcare subsidiary of the French Read more
NephroGuard has been selected as one of the Unirein Third-Party experimentation projects.
Bio Logbook's NephroGuard project joins forces with Unirein to optimize management Read more
Bio Logbook reaches a major milestone with the publication of a ground-breaking study in the journal CCA Clinica Chimica Acta.
It is with great pride that Bio Logbook announces the publication of its first study Read more
First publication in the collaboration between Bio Logbook and the LS2N laboratory
Bio Logbook announces the publication of the first scientific article resulting from the CIFRE thesis of Read more
BioLogbook launches its AI Human Guarantee pilot project in Medical Biology.
We are proud to announce the launch of our AI Human Guarantee pilot project Read more
Bio Logbook, winner of the European COVID-X fund for its solution to hospital overload.
Bio Logbook, the Nantes-based start-up specializing in precision medicine, wins the CHU Read more